Select language:

Belarus the first to receive the Russian COVID-19 vaccine

 / Главная / Russkiy Mir Foundation / News / Belarus the first to receive the Russian COVID-19 vaccine

Belarus the first to receive the Russian COVID-19 vaccine


Belarus has received the first batch of the Russian vaccine Sputnik V, RIA Novosti reports. The country became the first in the world to begin clinical trials of the drug after it was registered in the Russian Federation.

The Russian Direct Investment Fund (RDIF) explained that the vaccination of Belarusian volunteers would start from the beginning of next month. It will take place as part of a double-blind, randomized, placebo-controlled study.

The RDIF added that the fund allocated funds for research in Belarus. 100 people are going to take part in them. The clinical trials will bring together eight medical institutions, two have already received vaccine batches.

The same tests will take place in Brazil, India, Saudi Arabia, Egypt and the United Arab Emirates.

According to the head of the RDIF, Kirill Dmitriev, the Russian vaccine is built on the platform of human adenovirus vectors. It is harmless to human health and has been tested for decades in more than 250 clinical studies.

At the same time, manufacturers in the West rely on little-studied technologies, Dmitriev noted. They face obstacles in clinical trials that postpone the introduction of drugs and negatively affect efforts to combat the coronavirus.

Russkiy Mir 

News by subject


Vladimir Kanevsky moved from St. Petersburg to the U.S. in the 1980s. He's got engaged in creating porcelain flowers instead of architecture, which was an unexpected move even for him. Now designers of international fame collect exquisite bouquets by Vladimir Kanevsky, and the best museums of the world arrange exhibitions of his works.